Obstetrician-gynecologists and the HPV Vaccine: Practice Patterns, Beliefs, and Knowledge
Obstetrician-gynecologists and the HPV Vaccine: Practice Patterns, Beliefs, and Knowledge
复制标题
DOI：
10.1016/j.jpag.2008.09.002
复制
发表时间：
2009-08-01
影响因子：
1.8
通讯作者：
Schulkin, Jay
中科院分区：
文献类型：
--
作者：
Leddy, Meaghan A.;Anderson, Britta L.;Schulkin, Jay
研究目的：人乳头瘤病毒（HPV）是美国最常见的性传播感染，年轻女孩在初次性行为后不久就可以感染。人乳头瘤病毒可导致宫颈癌、肛门生殖器癌和生殖器疣。已经研制出一种预防癌前病变的疫苗。设计：2007年5月至11月，美国妇产科医师协会（ACOG）向其研究员和初级研究员发放了一份包含37个条目的调查问卷。参与者：对3896名ACOG研究员和初级研究员进行了调查。在这些调查中，有771人是协作门诊研究网络（卡恩）的成员，他们自愿每年接受几次调查。其余的3125份问卷被发送给所有研究员和初级研究员在ACOG的第五区（俄亥俄州，肯塔基州，印第安纳州，密歇根州和安大略，加拿大）。应答率分别为51.0%和30.7%，分别为卡恩和区V。结果：那些谁管理疫苗，大多数提供HPV疫苗。大多数人都知道这种疫苗可以预防4种HPV类型。很少有人知道宫颈癌和生殖器疣的预防百分比。超过20%的人知道所有三个答案。只有少数人回答错误。大约15%的人认为HPV疫苗在怀孕期间是安全的。许多人同意成本是病人拒绝的原因，并从强制vaccine.Conclusion威慑：妇产科医生是知识渊博的HPV疫苗，并将其纳入实践。财政问题可能会限制广泛的免疫接种。
Study Objective: Human papillomavirus (HPV), the most common sexually transmitted infection in the United States, can be contracted by Young girls shortly after Sexual debut. Human papillomavirus can lead to cervical and anogenital cancers and genital warts. A vaccine has been developed to protect against precancerous lesions. We examined obstetrician-gynecologists' practices, opinions, and knowledge regarding this vaccine.Design: A 37-item questionnaire was Sent Out by the American College of Obstetricians and Gynecologists (ACOG) to its fellows and junior fellows between May and November of 2007.Participants: Surveys went to 3896 fellows and junior fellows of ACOG. Of these Surveys, 771 were Collaborative Ambulatory Research Network (CARN) members who have volunteered to receive several surveys per year. The remaining 3125 questionnaires were sent to all fellows and junior fellows in ACOG's District V (Ohio, Kentucky, Indiana, Michigan and Ontario, Canada). Response rates were 51.0% and 30.7% for CARN and District V, respectively.Results: Of those who administer vaccines, most offer the HPV vaccine. Most know this vaccine protects against 4 HPV types. Fewer knew the percentages of cervical cancers and genital warts prevented. Over 20% knew all 3 answers. Only a minority answered all incorrectly. Approximately 15% view HPV vaccine as safe in pregnancy. Many agree cost is a reason for patient refusal and a deterrent from mandating the vaccine.Conclusion: Obstetrician-gynecologists are knowledgeable of the HPV vaccine and are incorporating it into practice. Financial concerns may limit widespread immunization.